EUVIMEDEUVIMED entdecken
Crossref

Impact of TP53, KEAP1 and STK11 mutations in localized-stage NSCLC: A European thoracic oncology platform lungscape project

Miguel A Molina-Vila, Zoi Tsourti, Katerina Vervita, Jordi Bertran-Alamillo, Beatriz García-Peláez, Keith M Kerr, Lukas Bubendorf, Line Bille Madsen, Wojciech Biernat, Albrecht Stenzinger, Martina Haberecker, Fiona Blackhall und 10 weitere

European Journal of Cancer · 2026

DOI: 10.1016/j.ejca.2026.116583 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Miguel A Molina-Vila und 21 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Oncology, Pangaea Oncology, Dexeus University Hospital, Barcelona, Spain. Hauptthemen laut MEDLINE: Kelch-Like ECH-Associated Protein 1, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: ETOP IBCSG Partners Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kelch-Like ECH-Associated Protein 1Carcinoma, Non-Small-Cell LungLung NeoplasmsTumor Suppressor Protein p53Protein Serine-Threonine KinasesMutationBiomarkers, TumorHumansAMP-Activated Protein Kinase KinasesFemaleMaleMiddle AgedAgedPrognosisAdultNeoplasm Staging

Stichwörter der Autor:innen

KEAP1LocalizedMutationsNSCLCPredictivePrognosticSTK11TP53

Substanzen

Kelch-Like ECH-Associated Protein 1STK11 protein, humanKEAP1 protein, humanAMP-Activated Protein Kinase KinasesTumor Suppressor Protein p53Protein Serine-Threonine KinasesTP53 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Laboratory of Oncology, Pangaea Oncology, Dexeus University Hospital, Barcelona, Spain.
  • ETOP IBCSG Partners Foundation, ETOP Statistical Center, Frontier Science Foundation-Hellas, Greece.
  • Department of Pathology, Aberdeen Royal Infirmary - NHS Grampian, Aberdeen, United Kingdom.
  • Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
  • Pathology, Aarhus University Hospital, Aarhus, Denmark.
  • Pathomorphology Department, Medical University of Gdansk, Gdansk, Poland.

Förderung

  • ETOP IBCSG Partners Foundation

Zitieren

APA

Molina-Vila, M. A., Tsourti, Z., Vervita, K., Bertran-Alamillo, J., García-Peláez, B., Kerr, K. M., Bubendorf, L., Madsen, L. B., Biernat, W., Stenzinger, A., Haberecker, M., Blackhall, F., Pokharel, S., Jordana-Ariza, N., Vives-Usano, M., Vagenknecht, P., Dafni, U., Kammler, R., Finn, S. P., …, & Rosell, R. (2026). Impact of TP53, KEAP1 and STK11 mutations in localized-stage NSCLC: A European thoracic oncology platform lungscape project. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.116583

Vancouver

Molina-Vila MA, Tsourti Z, Vervita K, Bertran-Alamillo J, García-Peláez B, Kerr KM, et al. Impact of TP53, KEAP1 and STK11 mutations in localized-stage NSCLC: A European thoracic oncology platform lungscape project. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.116583

BibTeX
@article{MolinaVila2026,
  author = {Molina-Vila, Miguel A and Tsourti, Zoi and Vervita, Katerina and Bertran-Alamillo, Jordi and García-Peláez, Beatriz and Kerr, Keith M and Bubendorf, Lukas and Madsen, Line Bille and Biernat, Wojciech and Stenzinger, Albrecht and Haberecker, Martina and Blackhall, Fiona and Pokharel, Saraswati and Jordana-Ariza, Núria and Vives-Usano, Marta and Vagenknecht, Patrick and Dafni, Urania and Kammler, Roswitha and Finn, Stephen P and Peters, Solange and Stahel, Rolf A and Rosell, Rafael},
  title = {Impact of TP53, KEAP1 and STK11 mutations in localized-stage NSCLC: A European thoracic oncology platform lungscape project},
  journal = {European Journal of Cancer},
  year = {2026},
  doi = {10.1016/j.ejca.2026.116583}
}
Kostenlos starten →